[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365607-105":59,"doc-detail-365607-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","lzts2-methylation-as-a-potential-diagnostic-and-prognostic-marker-in-lihc-and-stad-evidence-from-bioinformatics-and-in-vitro-analyses","LZTS2 methylation as a potential diagnostic and prognostic marker in LIHC and STAD - Evidence from bioinformatics and in vitro analyses","","Rising cancer mortality, driven by limited reliable biomarkers, motivates a study of LZTS2 as a pan-cancer diagnostic and prognostic indicator, with particular attention to predictive value for immunotherapy and therapeutic targeting. Using bioinformatics analyses across tools and databases (UALCAN, KM-plotter, and TCGA) and experimental validation in LIHC and STAD cell models, the work evaluates expression patterns and clinical relevance. Results link LZTS2 mutations and levels to progression and survival, correlate with clinicopathological features, and integrate genetic, epigenetic, and immunological associations supported by qRT-PCR and qMSP.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/lzts2-methylation-as-a-potential-diagnostic-and-prognostic-marker-in-lihc-and-stad-evidence-from-bioinformatics-and-in-vitro-analyses/365607/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/lzts2-methylation-as-a-potential-diagnostic-and-prognostic-marker-in-lihc-and-stad-evidence-from-bioinformatics-and-in-vitro-analyses/365607.png","ImageObject",300,407,{"name":92,"@type":93},"Sophia Brooks","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is LZTS2 investigated as a diagnostic and prognostic marker?","Question",{"text":112,"@type":113},"Because cancer progression and mortality remain high and dependable biomarkers are lacking, the study evaluates whether LZTS2 can improve diagnosis and prognosis, including relevance to immunotherapy prediction and therapeutic targeting.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What approaches are used to study LZTS2 in LIHC and STAD?",{"text":117,"@type":113},"The study combines bioinformatics analyses using UALCAN, KM-plotter, and TCGA with experimental validation in LIHC and STAD cell lines, including qRT-PCR and quantitative methylation-specific PCR (qMSP).",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical associations are reported for LZTS2?",{"text":121,"@type":113},"LZTS2 mutations and expression levels are reported to correlate with cancer progression and patient survival, and LZTS2 expression is described as correlating with multiple clinicopathological parameters.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},365607,1790196796,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nLZTS2 methylation as a potential diagnostic and prognostic marker in LIHC and STAD: Evidence from bioinformatics and in vitro analyses  \nXiao Wang1,2,5, Yanwei Lu3,5, Ruiqi Liu3,5, Luanluan Huang3, Keke Xu3, Hao Xiong3,  \nDing Nan4, Yiyi Shou4, Hailong Sheng3, Haibo Zhang3􀀍, Xian Wang1􀀍 & Xiaoyan Chen1,3􀀍  \nThe rising mortality rate from cancer, driven by the absence of reliable biomarkers, highlights the pressing need for advanced diagnostic and prognostic strategies. This study investigates LZTS2’s role as a pan-cancer biomarker, emphasizing its predictive value for immunotherapy and therapeutic targeting. Unlike existing biomarkers such asAFP in hepatocellular carcinoma or HER2 in gastric cancer, which exhibit tissue-specific utility, LZTS2 demonstrates unique cross-cancer applicability, as evidenced by its consistent dysregulation in both liver hepatocellular carcinoma (LIHC) and stomach adenocarcinoma (STAD) alongside emerging associations with other malignancies. Leveraging advanced bioinformatics tools and databases including UALCAN, KM-plotter, and The Cancer Genome Atlas (TCGA), alongside experimental validation in LIHC and STAD cell lines, we analyze LZTS2 expression patterns and their clinical relevance. Notably, LZTS2’s dual role—acting as a tumor suppressor in some cancers while promoting oncogenesis in others—distinguishes it from conventional single-function markers, offering novel insights into its regulatory versatility. Our findings reveal that LZTS2 mutations and expression levels are closely associated with cancer progression and patient survival, solidifying its potential as a prognostic biomarker. Notably, LZTS2 expression correlates with various clinicopathological parameters, underscoring its significance in cancer biology. Pathway analysis highlights LZTS2’s involvement in critical biological processes, providing actionable insights for therapeutic interventions. Quantitative real-time polymerase chain reaction (qRT-PCR) and quantitative methylation-specific PCR (qMSP) experimental validations confirm these results, further establishing LZTS2’s utility as a multi-dimensional biomarker that integrates genetic, epigenetic, and immunological features—a capability rarely observed in existing markers. This comprehensive analysis positions LZTS2 as a pivotal player in cancer progression, opening promising avenues for enhanced clinical management.  \nKeywords LZTS2, Neoplasm, Biomarkers, Metastasis, Methylation, qMSP  \nCancer is a leading global health challenge and remains the second most prevalent cause of death worldwide, with approximately 19.3 million new cases and 10 million cancer-related deaths were reported in 20211. The ongoing burden of cancer, particularly in advanced stages, is largely attributed to metastasis, which significantly reduces patient survival rates. In the United States, there were approximately 1.9 million new cancer diagnosesand over 600,000 cancer-related deaths in 2021, underscoring the significant impact of this issue2. Worldwide, the frequency of cancer diagnoses is on the rise, influenced by an array of internal risk factors including genetic predispositions, hormonal imbalances, and metabolic disorders, as well as external factors such as smoking, dietary patterns, and environmental exposures3,4.  \n1Department of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. 2Department of Medical Oncology, Cancer Center, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China. 3Department of Radiation Oncology, Cancer Center, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China. 4Graduate Department, Hangzhou Normal University, Hangzhou, Zhejiang, China.  \n5Xiao Wang, Yanwei Lu, and Ruiqi Liu have contributed equall","cbCaigTGFuxi6BMq","https://ap.wps.com/l/cbCaigTGFuxi6BMq","pdf",5609159,17,"English","# Background and Rationale\n## Need for reliable diagnostic and prognostic biomarkers\n## Focus on LIHC and STAD\n# Methods\n## Bioinformatics analyses (UALCAN, KM-plotter, TCGA)\n## In vitro validation in LIHC and STAD cell lines\n## qRT-PCR and qMSP\n# Findings\n## LZTS2 cross-cancer dysregulation\n## Association with progression and patient survival\n## Clinicopathological correlations\n## Pathway involvement\n# Implications","[{\"question\":\"Why is LZTS2 investigated as a diagnostic and prognostic marker?\",\"answer\":\"Because cancer progression and mortality remain high and dependable biomarkers are lacking, the study evaluates whether LZTS2 can improve diagnosis and prognosis, including relevance to immunotherapy prediction and therapeutic targeting.\"},{\"question\":\"What approaches are used to study LZTS2 in LIHC and STAD?\",\"answer\":\"The study combines bioinformatics analyses using UALCAN, KM-plotter, and TCGA with experimental validation in LIHC and STAD cell lines, including qRT-PCR and quantitative methylation-specific PCR (qMSP).\"},{\"question\":\"What clinical associations are reported for LZTS2?\",\"answer\":\"LZTS2 mutations and expression levels are reported to correlate with cancer progression and patient survival, and LZTS2 expression is described as correlating with multiple clinicopathological parameters.\"}]","LZTS2 methylation as a potential diagnostic and prognostic marker in LIHC and STAD - Evidence from bioinformatics and in vitro analyses | PDF",1790161444,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4b082544966c90d59ba36112bff015c.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8fe7800493279102a6123f03240f95a.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2de8a718577bbc442f771116595db97.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/515f4e60199d6c3ed3a360efea2e54b3.webp",980,1287]